RARB and breast cancer: Nagraes et al. [38] sought to investigate whether the aberrant DNA methylation of cancer-associated genes was related to urinary BC recurrence and suggested that RARB and RASSF1A gene methylation should be considered potential diagnostic markers, particularly in studies aiming at early recurrence detection.